1101464

Merck & Co. Inc — FEI 2211017

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rahway, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
755721 CFR 312.56(b)Notification of FDA of termination of investigator